1-9 of 9
Michael A. Morgan, PhD
Close
Sort by
Journal Articles

High-Throughput Drug Screening Identifies Pyrimethamine As a Potent and Selective Inhibitor of Acute Myeloid Leukemia

Amit Sharma, PhD, Nidhi Jyotsana, Courteney K. Lai, BSc, Anuhar Chaturvedi, PhD, Kerstin Görlich, Cecilia Murphy, Jan E. Blanchard, Arnold Ganser, Eric Brown, John A. Hassell, R. Keith Humphries, MD PhD, Michael A Morgan, PhD, Michael Heuser, MD
Journal: Blood
Blood (2014) 124 (21): 2304.
https://doi.org/10.1182/blood.V124.21.2304.2304
Published: 2014
Journal Articles

NADH Dehydrogenase Subunit 4 ( ND4 ) Mutations in Pediatric Acute Myeloid Leukemia

Michael A Morgan, PhD, Birgit Markus, MD, Malou Hermkens, Frederik Damm, MD, Katarina Reinhardt, PhD, Martin Zimmermann, PhD, Iris H.I.M. Hollink, MD, PhD, MM van den Heuvel-Eibrink, MD, PhD, C. Michel Zwaan, MD, PhD, Felicitas Thol, MD, Tania Bunke, Dessislava Bogoeva, Christoph WM Reuter, MD, PhD, Arnold Ganser, Dirk Reinhardt, MD
Journal: Blood
Blood (2012) 120 (21): 1380.
https://doi.org/10.1182/blood.V120.21.1380.1380
Published: 2012
Journal Articles

Frequency and Prognostic Impact of NUP98/NSD1 Translocations in Adult AML and MDS Patients

Felicitas Thol, MD, Britta Kölking, Iris H.I.M. Hollink, MD, PhD, Frederik Damm, MD, Marry M. van den Heuvel-Eibrink, C. Michel Zwaan, MD, PhD, Gesine Bug, Oliver G. Ottmann, MD, Katharina Wagner, MD, Michael A Morgan, PhD, Wolf-Karsten Hofmann, Gudrun Göhring, MD, Brigitte Schlegelberger, Jürgen Krauter, Prof. Dr. med., Arnold Ganser, Michael Heuser, MD
Journal: Blood
Blood (2012) 120 (21): 1402.
https://doi.org/10.1182/blood.V120.21.1402.1402
Published: 2012
Journal Articles

ID1 Expression Correlates with CEBPA Mutational Status and Is Not An Independent Risk Factor in Cytogenetically Normal AML,

Katharina Wagner, MD, Frederik Damm, MD, Michael A Morgan, PhD, Felicitas Thol, M.D., Haiyang Yun, Gudrun Göhring, MD, Brigitte Schlegelberger, M.D., Michael Heuser, M.D., Arnold Ganser, MD, Jürgen Krauter, MD
Journal: Blood
Blood (2011) 118 (21): 3554.
https://doi.org/10.1182/blood.V118.21.3554.3554
Published: 2011
Journal Articles

Modulation of Anthracycline-Induced Cytotoxicity by Targeting the Prenylated Prenylome in Myeloid Leukemia Cells

Michael A Morgan, PhD, Fredrick O Onono, Peter H Spielmann, Thangaiah Subramanian, Michaela Scherr, Letizia Venturinin, Iris Dallmann, Arnold Ganser, MD, Christoph W.M. Reuter
Journal: Blood
Blood (2011) 118 (21): 1418.
https://doi.org/10.1182/blood.V118.21.1418.1418
Published: 2011
Journal Articles

Prevalence and Clinical Effect of TET2 Mutations in Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Birgit Markus, MD, Felicitas Thol, M.D., Michael A Morgan, PhD, Katharina Wagner, MD, Michael Heuser, M.D., Juergen Krauter, MD, Arnold Ganser, MD, Frederik Damm, MD
Journal: Blood
Blood (2011) 118 (21): 1448.
https://doi.org/10.1182/blood.V118.21.1448.1448
Published: 2011
Journal Articles

Potentiation of Topoisomerase II Inhibitor-Mediated Myeloid Leukemia Cell Kill by Farnesyltransferase Inhibitor L-744,832.

Fredrick O. Onono, MSc, Michael A. Morgan, PhD, Jeanny Wegner, MD, Arnold Ganser, MD/PhD, Christoph W.M. Reuter, MD/PhD
Journal: Blood
Blood (2007) 110 (11): 3479.
https://doi.org/10.1182/blood.V110.11.3479.3479
Published: 2007
Journal Articles

Characterization of a Novel R-RAS Mutation Cloned from Primary AML Cells.

Christoph W.M. Reuter, MD, PhD, Erdem Aydilek, MD, Fredrick O. Onono, Michael A. Morgan, PhD, Kristine A. Henningfeld, PhD, Arnold Ganser, MD/PhD
Journal: Blood
Blood (2006) 108 (11): 1439.
https://doi.org/10.1182/blood.V108.11.1439.1439
Published: 2006
Journal Articles

Prenylation Inhibitors Block IL-6 and IGF-1 Dependent Activation of RAS Signaling in Multiple Myeloma Cells.

Christoph W.M. Reuter, MD, PhD, Michael A. Morgan, PhD, Dietrich Peest, MD/PhD, Arnold Ganser, MD/PhD
Journal: Blood
Blood (2005) 106 (11): 3373.
https://doi.org/10.1182/blood.V106.11.3373.3373
Published: 2005